BioStem Technologies, Inc.
BSEM
$11.26
-$0.6979-5.84%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 206.35% | 137.58% | 148.46% | 50.85% |
| Total Depreciation and Amortization | -- | 10.60% | -10.34% | -9.58% | 5.13% |
| Total Amortization of Deferred Charges | -- | 641.26% | -- | -- | -- |
| Total Other Non-Cash Items | -- | -14.02% | 52.49% | 52.49% | 45.09% |
| Change in Net Operating Assets | -- | -3,078.77% | -1,403.55% | -1,546.61% | -883.00% |
| Cash from Operations | -- | 691.61% | 306.69% | 306.85% | -136.82% |
| Capital Expenditure | -- | -97.59% | -293.41% | -293.41% | 69.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 53.52% | 53.52% | 53.52% | 53.52% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -1,310.36% | 123.88% | 123.88% | 200.00% |
| Cash from Investing | -- | -450.48% | -8.70% | -8.70% | 88.87% |
| Total Debt Issued | -- | -97.37% | -69.98% | -69.98% | 47.97% |
| Total Debt Repaid | -- | -33.96% | -119.71% | -120.33% | -124.94% |
| Issuance of Common Stock | -- | 414.06% | 431.96% | 431.96% | 830.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -38.61% | -10.96% | -11.19% | 246.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 1,656.85% | 695.98% | 695.98% | 174.86% |